<unk>  of multiple endocrine neoplasia type 1 associated<unk>  improves morbidity and survival rates of patients. Biochemical<unk>  depends on measuring gastrointestinal hormones such as gastrin, insulin, glucagon, VIP, pancreatic polypeptide, chromogranin A, prolactin, and IGF-1 in all patients. Radiological<unk>  should include an MRI of the pancreas, adrenal glands, and pituitary and repeated every 2 years. All high-risk patients should be offered genetic counseling and MEN1 mutation testing. If the genetic tests result is positive, patients should have a periodic clinical, biochemical, and radiological<unk>  program.
Glucagonoma screening
Hypopituitarism screening
Medullary thyroid cancer screening
Autoimmune polyendocrine syndrome screening
Follicular thyroid cancer screening
Adrenal atrophy screening
Adrenal insufficiency screening
Hypoglycemia screening